Carotid Artery Stenting Medication

1. North American Symptomatic Carotid Endarterectomy Trial Collaborators., Barnett HJM, Taylor DW, Haynes RB, Sackett DL, Peerless SJ, et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991 Aug 15. 325 (7):445-53. [QxMD MEDLINE Link].

2. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998 Nov 12. 339 (20):1415-25. [QxMD MEDLINE Link].

3. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA. 1995 May 10. 273 (18):1421-8. [QxMD MEDLINE Link].

4. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists' Collaborative Group. Lancet. 1991 May 25. 337 (8752):1235-43. [QxMD MEDLINE Link].

5. Aronow HD, Collins TJ, Gray WA, Jaff MR, Kluck BW, Patel RA, et al. SCAI/SVM expert consensus statement on Carotid Stenting: Training and credentialing for Carotid Stenting. Catheter Cardiovasc Interv. 2016 Feb 1. 87 (2):188-99. [QxMD MEDLINE Link].

6. [Guideline] AbuRahma AF, Avgerinos ED, Chang RW, Darling RC 3rd, Duncan AA, Forbes TL, et al. Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease. J Vasc Surg. 2022 Jan. 75 (1S):4S-22S. [QxMD MEDLINE Link]. [Full Text].

7. Naylor AR, Bolia A, Abbott RJ, Pye IF, Smith J, Lennard N, et al. Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: a stopped trial. J Vasc Surg. 1998 Aug. 28 (2):326-34. [QxMD MEDLINE Link].

8. Brooks WH, McClure RR, Jones MR, Coleman TC, Breathitt L. Carotid angioplasty and stenting versus carotid endarterectomy: randomized trial in a community hospital. J Am Coll Cardiol. 2001 Nov 15. 38 (6):1589-95. [QxMD MEDLINE Link].

9. Brooks WH, Jones MR, Gisler P, McClure RR, Coleman TC, Breathitt L, et al. Carotid angioplasty with stenting versus endarterectomy: 10-year randomized trial in a community hospital. JACC Cardiovasc Interv. 2014 Feb. 7 (2):163-168. [QxMD MEDLINE Link].

10. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet. 2001 Jun 2. 357 (9270):1729-37. [QxMD MEDLINE Link].

11. Yadav JS, Wholey MH, Kuntz RE, et al, Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004 Oct 7. 351 (15):1493-501. [QxMD MEDLINE Link].

12. Brott TG, Hobson RW 2nd, Howard G, et al, CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010 Jul 1. 363 (1):11-23. [QxMD MEDLINE Link]. [Full Text].

13. Lal BK, Beach KW, Roubin GS, Lutsep HL, Moore WS, Malas MB, et al. Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial. Lancet Neurol. 2012 Sep. 11 (9):755-63. [QxMD MEDLINE Link]. [Full Text].

14. Gorgulu S, Sahin M, Norgaz NT, Pala S, Sarı M, Yalcin AA, et al. Carotid artery stenting without embolic protection: A randomized multicenter trial (the CASWEP trial). Interv Neuroradiol. 2022 Apr 26. 15910199221094388. [QxMD MEDLINE Link].

15. Kargiotis O, Safouris A, Magoufis G, Georgala M, Roussopoulou A, Stamboulis E, et al. The Role of Neurosonology in the Diagnosis and Management of Patients with Carotid Artery Disease: A Review. J Neuroimaging. 2018 May. 28 (3):239-251. [QxMD MEDLINE Link].

16. de Donato G, Pasqui E, Alba G, Giannace G, Panzano C, Cappelli A, et al. Clinical considerations and recommendations for OCT-guided carotid artery stenting. Expert Rev Cardiovasc Ther. 2020 Apr. 18 (4):219-229. [QxMD MEDLINE Link].

17. Xu X, Huang F, Shi X, Liu R, Han Y, Li M, et al. Optical Coherence Tomography Evaluation of Carotid Artery Stenosis and Stenting in Patients With Previous Cervical Radiotherapy. Front Neurosci. 2022. 16:861511. [QxMD MEDLINE Link]. [Full Text].

18. [Guideline] Zierler RE, Jordan WD, Lal BK, Mussa F, Leers S, Fulton J, et al. The Society for Vascular Surgery practice guidelines on follow-up after vascular surgery arterial procedures. J Vasc Surg. 2018 Jul. 68 (1):256-284. [QxMD MEDLINE Link]. [Full Text].

19. Paraskevas KI, Antonopoulos CN, Kakisis JD, Geroulakos G. An updated systematic review and meta-analysis of results of transcervical carotid artery stenting with flow reversal. J Vasc Surg. 2020 Oct. 72 (4):1489-1498.e1. [QxMD MEDLINE Link].

20. [Guideline] Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neuro... Circulation. 2011 Jul 26. 124(4):e54-130. [QxMD MEDLINE Link].

21. [Guideline] Naylor AR, Ricco JB, de Borst GJ, Debus S, de Haro J, Halliday A, et al. Editor's Choice - Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2018 Jan. 55 (1):3-81. [QxMD MEDLINE Link]. [Full Text].

22. Chang CK, Huded CP, Nolan BW, Powell RJ. Prevalence and clinical significance of stent fracture and deformation following carotid artery stenting. J Vasc Surg. 2011 Sep. 54 (3):685-90. [QxMD MEDLINE Link].

23. Cui L, Han Y, Zhang S, Liu X, Zhang J. Safety of Stenting and Endarterectomy for Asymptomatic Carotid Artery Stenosis: A Meta-Analysis of Randomised Controlled Trials. Eur J Vasc Endovasc Surg. 2018 May. 55 (5):614-624. [QxMD MEDLINE Link].

24. Yuan G, Zhou S, Wu W, Zhang Y, Lei J, Huang B. Carotid Artery Stenting Versus Carotid Endarterectomy for Treatment of Asymptomatic Carotid Artery Stenosis. Int Heart J. 2018 May 30. 59 (3):550-558. [QxMD MEDLINE Link].

25. Xu X, Feng Y, Bai X, Ma Y, Wang Y, Chen Y, et al. Risk factors for silent new ischemic cerebral lesions following carotid artery stenting. Neuroradiology. 2020 Sep. 62 (9):1177-1184. [QxMD MEDLINE Link].

26. Li B, Fan W, Yang Y, Qu X, Tong J, Liu Y, et al. Peri-procedural variables and outcomes of long-period hemodynamic instability after carotid artery angioplasty and stenting. Vascular. 2022 Apr 24. 17085381221091369. [QxMD MEDLINE Link].

Faisal Aziz, MD Assistant Professor of Surgery, Divsion of Vascular and Endovascular Surgery, Department of Surgery, Pennsylvania State University College of Medicine

Faisal Aziz, MD is a member of the following medical societies: American College of Surgeons, American Medical Association

Disclosure: Nothing to disclose.

Anthony J Comerota, MD, FACS, FACC, FRACS Medical Director, Eastern Region Heart and Vascular Institute, Inova Cardiac and Vascular Surgery

Anthony J Comerota, MD, FACS, FACC, FRACS is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American College of Chest Physicians, American College of Surgeons, American Heart Association, American Stroke Association, American Surgical Association, American Venous Forum, Association for Academic Surgery, Eastern Vascular Society, Society for Clinical Vascular Surgery, Society for Vascular Surgery, Society of University Surgeons

Disclosure: Received honoraria from BMS for speaking and teaching; Received consulting fee from BMS for consulting; Received grant/research funds from BMS for research studies; Received honoraria from Covidien for speaking and teaching; Received consulting fee from Covidien for consulting; Received honoraria from Otsuka for speaking and teaching; Received honoraria from Sanofi/Aventis for speaking and teaching; Received consulting fee from Sanofi/Aventis for consulting; Received grant/research funds from Sa.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Karlheinz Peter, MD, PhD Professor of Medicine, Monash University; Head of Centre of Thrombosis and Myocardial Infarction, Head of Division of Atherothrombosis and Vascular Biology, Associate Director, Baker Heart Research Institute; Interventional Cardiologist, The Alfred Hospital, Australia

Karlheinz Peter, MD, PhD is a member of the following medical societies: American Heart Association, German Cardiac Society, Cardiac Society of Australia and New Zealand

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article